# Safety and Performance Study of the Reliance 4-Front Lead

Study · id `cardio:ct-nct01772576` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01772576](<https://clinicaltrials.gov/study/NCT01772576>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01772576

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 167 participants.

## Technical summary

Registry record NCT01772576. Allocation not applicable; no masking; primary purpose treatment. Start 2012-10 (registry gives no type); primary completion 2014-06 (actual). Results posted on 2017-06-02.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 167 participants (enrolled count; ClinicalTrials.gov record NCT01772576, source copy `cardio:ctgov-nct01772576-2017-07-02`, retrieved 2026-10-26)
- Start date: 2012-10 (registry gives no type) (ClinicalTrials.gov record NCT01772576, source copy `cardio:ctgov-nct01772576-2017-07-02`, retrieved 2026-10-26)
- Primary completion: 2014-06 (actual) (ClinicalTrials.gov record NCT01772576, source copy `cardio:ctgov-nct01772576-2017-07-02`, retrieved 2026-10-26)
- Completion: 2016-08 (actual) (ClinicalTrials.gov record NCT01772576, source copy `cardio:ctgov-nct01772576-2017-07-02`, retrieved 2026-10-26)
- Results first posted: 2017-06-02 (ClinicalTrials.gov record NCT01772576, source copy `cardio:ctgov-nct01772576-2017-07-02`, retrieved 2026-10-26)
- Countries: Austria; China; Denmark; France; Germany; Israel; Italy; Portugal; Spain; Sweden; United Kingdom (ClinicalTrials.gov record NCT01772576, source copy `cardio:ctgov-nct01772576-2017-07-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01772576-2017-07-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Performance Study of the Reliance 4-Front Lead
- Condition: Tachycardia
- Intervention (Device): Reliance 4-Front lead implantation
- Lead sponsor: Boston Scientific Corporation
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry lists this organization as the lead sponsor: Boston Scientific (`cardio:boston-scientific`)

## Provenance

Content hash: f94d87572309cb4533bde82b0e4b388a6b95572cc39ba27c952bd77d5be4afc5
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
